Breast Carcinoma — Trials

Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 873
Recruiting: 477
Ph III recruiting: 54
Growth YoY: 0%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07698106	Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC	not yet recruiting	Phase 1 / Phase 2	60	University Health Network, TorontoOTHER	0	Sep 28, 2026	clinicaltrials
NCT07743723	A Study of IOV-5001 in Adults With Advanced Solid Tumors	not yet recruiting	Phase 1 / Phase 2	106	Iovance Biotherapeutics, Inc.INDUSTRY	1	Sep 15, 2026	clinicaltrials